http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105424944-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-96444 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-56 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-86 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N11-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N11-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-86 |
| filingDate | 2015-07-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2019-11-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2019-11-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-105424944-B |
| titleOfInvention | Detection and classification of anticoagulants with agglutination assays |
| abstract | The present invention provides methods for detecting therapeutically relevant or higher amounts of an anticoagulant in a patient. The present invention also includes methods of classifying anticoagulants as anti-factor Xa anticoagulants or direct thrombin inhibitors using an agglutination assay in the presence of a viper venom reagent. The present invention also provides methods for detecting and classifying therapeutically relevant or higher amounts of anticoagulants in a patient. The present invention further includes methods for identifying and classifying anticoagulants as anti-Factor Xa anticoagulants in the presence of factor Xa reagents. |
| priorityDate | 2014-07-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 155.